179 related articles for article (PubMed ID: 34981056)
41. Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
bioRxiv; 2022 Feb; ():. PubMed ID: 35169798
[TBL] [Abstract][Full Text] [Related]
42. The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination.
Hastert FD; Hein S; von Rhein C; Benz NI; Husria Y; Oberle D; Maier TJ; Hildt E; Schnierle BS
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632550
[TBL] [Abstract][Full Text] [Related]
43. A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant.
Minka SO; Minka FH
Immunol Lett; 2022 Mar; 243():38-43. PubMed ID: 35131373
[TBL] [Abstract][Full Text] [Related]
44. Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.
Vogt AS; Augusto G; Martina B; Chang X; Nasrallah G; Speiser DE; Vogel M; Bachmann MF; Mohsen MO
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632499
[TBL] [Abstract][Full Text] [Related]
45. Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody.
Lai KT; Lai Wan Loong EY; Fung TL; Luk LW; Lau CC; Zee JS; Ma ES; Tang BS
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455305
[TBL] [Abstract][Full Text] [Related]
46. At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
Singanallur NB; van Vuren PJ; McAuley AJ; Bruce MP; Kuiper MJ; Gwini SM; Riddell S; Goldie S; Drew TW; Blasdell KR; Tachedjian M; Mangalaganesh S; Chahal S; Caly L; Druce JD; Juno JA; Kent SJ; Wheatley AK; Vasan SS
Front Immunol; 2022; 13():883612. PubMed ID: 35655773
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital.
Sammartino JC; Cassaniti I; Ferrari A; Giardina F; Ferrari G; Zavaglio F; Paolucci S; Lilleri D; Piralla A; Baldanti F; Percivalle E
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632457
[TBL] [Abstract][Full Text] [Related]
48. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron.
Suntronwong N; Yorsaeng R; Puenpa J; Auphimai C; Thongmee T; Vichaiwattana P; Kanokudom S; Duangchinda T; Chantima W; Pakchotanon P; Assawakosri S; Nilyanimit P; Klinfueng S; Wongsrisang L; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335023
[TBL] [Abstract][Full Text] [Related]
50. Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern.
Valanparambil R; Carlisle J; Linderman S; Akthar A; Millett RL; Lai L; Chang A; McCook A; Switchenko J; Nasti T; Saini M; Andreas Wieland AW; Manning K; Ellis M; Moore K; Foster S; Floyd K; Davis-Gardner M; Viswanadh Edara V; Patel M; Steur C; Nooka A; Green F; Johns M; O Brein F; Shanmugasundaram U; Zarnitsyna V; Ahmed H; Nyhoff L; Mantus G; Garett M; Edupuganti S; Behra M; Antia R; Wrammert J; Suthar M; Dhodapkar M; Ramalingam S; Ahmed R
medRxiv; 2022 Jan; ():. PubMed ID: 35018383
[TBL] [Abstract][Full Text] [Related]
51. Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
Branche A; Rouphael N; Diemert D; Falsey A; Losada C; Baden LR; Frey S; Whitaker J; Little S; Anderson E; Walter E; Novak R; Rupp R; Jackson L; Babu T; Kottkamp A; Luetkemeyer A; Immergluck L; Presti R; Backer M; Winokur P; Mahgoub S; Goepfert P; Fusco D; Malkin E; Bethony J; Walsh E; Graciaa D; Samaha H; Sherman A; Walsh S; Abate G; Oikonomopoulou Z; El Sahly H; Martin T; Kamidani S; Smith M; Ladner B; Porterfield L; Dunstan M; Wald A; Davis T; Atmar R; Mulligan M; Lyke K; Posavad C; Meagher M; Stephens D; Neuzil K; Abebe K; Hill H; Albert J; Telu K; Mu J; Lewis T; Giebeig L; Eaton A; Netzl A; Wilks S; Tureli S; Makhene M; Crandon S; Montefiori D; Makowski M; Smith D; Nayak S; Roberts P; Beigel J
Res Sq; 2023 May; ():. PubMed ID: 37205592
[TBL] [Abstract][Full Text] [Related]
52. Variability in SARS-Cov-2 IgG Antibody Affinity To Omicron and Delta Variants in Convalescent and Community mRNA Vaccinated Individuals.
Tu MK; Chiang SH; Wong DTW; Strom CM
medRxiv; 2022 Mar; ():. PubMed ID: 35262090
[TBL] [Abstract][Full Text] [Related]
53. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.
Edara VV; Floyd K; Lai L; Gardner M; Hudson W; Piantadosi A; Waggoner JJ; Babiker A; Ahmed R; Xie X; Lokugamage K; Menachery V; Shi PY; Suthar MS
medRxiv; 2021 Feb; ():. PubMed ID: 33564782
[TBL] [Abstract][Full Text] [Related]
54. Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF; Almeida NBF; Filgueiras PS; Corsini CA; Gomes SVC; de Miranda DAP; de Assis JV; de Souza Silva TB; Alves PA; da Rocha Fernandes G; de Oliveira JG; Rahal P; Grenfell RFQ; Nogueira ML
Commun Med (Lond); 2022; 2():76. PubMed ID: 35784447
[TBL] [Abstract][Full Text] [Related]
55. Update on omicron variant: What we know so far.
Choudhary G; Prajapat M; Kumaravel J; Prabha PK; Sarma P; Handa V; Kaur H; Patel AP; Medhi B
Indian J Pharmacol; 2022; 54(1):41-45. PubMed ID: 35343206
[TBL] [Abstract][Full Text] [Related]
56. mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1.
Davis-Gardner ME; Lai L; Wali B; Samaha H; Solis D; Lee M; Porter-Morrison A; Hentenaar IT; Yamamoto F; Godbole S; Douek DC; Lee FE; Rouphael N; Moreno A; Pinsky BA; Suthar MS
bioRxiv; 2022 Nov; ():. PubMed ID: 36380757
[TBL] [Abstract][Full Text] [Related]
57. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
Front Immunol; 2021; 12():793191. PubMed ID: 34975897
[TBL] [Abstract][Full Text] [Related]
58. Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization.
Doria-Rose NA; Shen X; Schmidt SD; O'Dell S; McDanal C; Feng W; Tong J; Eaton A; Maglinao M; Tang H; Manning KE; Edara VV; Lai L; Ellis M; Moore K; Floyd K; Foster SL; Atmar RL; Lyke KE; Zhou T; Wang L; Zhang Y; Gaudinski MR; Black WP; Gordon I; Guech M; Ledgerwood JE; Misasi JN; Widge A; Roberts PC; Beigel J; Korber B; Pajon R; Mascola JR; Suthar MS; Montefiori DC
medRxiv; 2021 Dec; ():. PubMed ID: 34931200
[TBL] [Abstract][Full Text] [Related]
59. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
60. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
Noor R; Shareen S; Billah M
Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
